Krsnaa Diagnostics Ltd (NSE: KRSNAA, BSE: 543328) is a Pune, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹1,617 Cr, it ranks #1,305 by market cap among the 6,189 Indian listed companies on FinBizNet, and #5 of 18 in Medical Diagnostic Centres. At ₹498.40 (as of 26 Oct 2026), the share price is 40.5% below its 52-week high of ₹838.00 and 1.1% above its 52-week low of ₹493.00. The share price is down 38.8% over one year and down 8.5% over three months.
| Current Price | ₹498.40 |
|---|---|
| Market Cap | ₹1,617 Cr |
| NSE Symbol | KRSNAA |
| BSE Code | 543328 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 16.1 |
| Return on Equity | 10.89% |
| Return on Assets | 4.89% |
| 52-Week Range | ₹493.00 – ₹838.00 |
| 1-Year Price Change | -38.8% |
| 3-Month Price Change | -8.5% |
| Beta (1Y) | 0.36 |
| Dividend Yield | 0.40% |
| Headquarters | Pune, Maharashtra |
| Website | krsnaadiagnostics.com |
| Revenue | ₹236 Cr |
|---|---|
| Net Profit | ₹17 Cr |
| Net Margin | 7.0% |
| EPS (Basic) | ₹5.10 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
1. Radiology and Pathology Services-This segment provides diagnostic services. It offers radiology and pathology services for X-ray, CT-scan, MRI, mammography, tele-reporting, and various types of blood and urine investigations.
1. Diagnostic Services in Radiology and Pathology Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | ₹14,311 Cr | 82.8 | 19.70% | ₹231 Cr | +40.7% |
| Metropolis Healthcare Limited | ₹10,849 Cr | 56.9 | 13.37% | ₹450 Cr | +7.3% |
| Throcare Technologies Ltd | ₹7,357 Cr | 45.3 | 28.74% | ₹240 Cr | +8.9% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,434 Cr | 34.3 | 25.22% | — | +20.0% |
| Krsnaa Diagnostics Ltd | ₹1,617 Cr | 16.1 | 10.89% | ₹236 Cr | -38.8% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,559 Cr | 48.4 | 13.84% | ₹88 Cr | -0.3% |
| Gaudium IVF and Women Health Limited | ₹670 Cr | 23.5 | 16.08% | ₹19 Cr | — |
| Chandan Healthcare Limited | ₹535 Cr | 20.3 | — | ₹81 Cr | — |
| Star Imaging And Path Lab Limi | ₹130 Cr | 6.7 | — | — | -43.0% |
Listed by market capitalisation. Ratios are shown for context only.
Krsnaa Diagnostics Ltd is trading at ₹498.40, with a market capitalisation of ₹1,617 Cr.
Krsnaa Diagnostics Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Krsnaa Diagnostics Ltd has a P/E of 16.1 and a return on equity of 10.89%.
Krsnaa Diagnostics Ltd is listed on the NSE under the symbol KRSNAA and on the BSE under the scrip code 543328.
Krsnaa Diagnostics Ltd's share price is down 38.8% over one year and down 8.5% over three months. Its 52-week range is ₹493.00 to ₹838.00.
In Q1 FY27, Krsnaa Diagnostics Ltd reported revenue of ₹236 Cr and net profit of ₹17 Cr, with basic EPS of ₹5.1 (consolidated, parsed from the company's exchange filing).
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.